Covid: Precautionary doses will not be mix-and-match, announces government

India's Covid-19 vaccination drive commenced on January 16, 2021 and so far the cumulative vaccination coverage has exceeded 1.47 billion

Balram Bhargava
DG ICMR Balram Bhargava addresses a press briefing on the actions taken, preparedness and updates on COVID-19, in New Delhi (Photo: PTI)
ANI General News
1 min read Last Updated : Jan 05 2022 | 6:13 PM IST

The precautionary COVID-19 vaccine dose, which is to be given to healthcare and frontline workers, and those over 60 years of age with co-morbidities from January 10, will be the same vaccine as administered previously in the first two doses, said Dr VK Paul, Member-Health, NITI Aayog.

"Precautionary COVID-19 vaccine dose will be the same vaccine as has been given previously. Those who've received Covaxin will receive Covaxin, those who've received primary two doses of Covishield will receive Covishield," Dr Paul said during media briefing of Union Health Ministry.

Prime Minister Narendra Modi had on December 25 announced that healthcare and frontline workers will be given 'precaution dose' from January 10 this year. He also said that senior citizens facing co-morbidities will have the option to go for precaution dose of COVID-19 on the advice of their doctors.

India's COVID-19 vaccination drive commenced on January 16, 2021 and so far the cumulative vaccination coverage has exceeded 147.72 crore.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jan 05 2022 | 6:13 PM IST

Next Story